IN2014DN10404A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN10404A IN2014DN10404A IN10404DEN2014A IN2014DN10404A IN 2014DN10404 A IN2014DN10404 A IN 2014DN10404A IN 10404DEN2014 A IN10404DEN2014 A IN 10404DEN2014A IN 2014DN10404 A IN2014DN10404 A IN 2014DN10404A
- Authority
- IN
- India
- Prior art keywords
- pde7
- addictions
- phosphodiesterase
- directed
- disclosure
- Prior art date
Links
- 102000010984 Type 7 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 2
- 108010037622 Type 7 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 2
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 abstract 1
- 208000030990 Impulse-control disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261643611P | 2012-05-07 | 2012-05-07 | |
| US13/835,607 US9220715B2 (en) | 2010-11-08 | 2013-03-15 | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| PCT/US2013/039866 WO2013176877A2 (en) | 2012-05-07 | 2013-05-07 | Treatment of addiction and impulse-control disorders using pde7 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN10404A true IN2014DN10404A (cg-RX-API-DMAC7.html) | 2015-08-14 |
Family
ID=49624481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN10404DEN2014 IN2014DN10404A (cg-RX-API-DMAC7.html) | 2012-05-07 | 2013-05-07 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2846805B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2015521177A (cg-RX-API-DMAC7.html) |
| CN (3) | CN114984229A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013266793B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2871151C (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014DN10404A (cg-RX-API-DMAC7.html) |
| PL (1) | PL2846805T3 (cg-RX-API-DMAC7.html) |
| RS (1) | RS58381B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2846805T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013176877A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| NZ628055A (en) | 2010-11-08 | 2016-03-31 | Omeros Corp | Treatment of addiction and impulse-control disorders using pde7 inhibitors |
| KR20190040054A (ko) | 2016-08-26 | 2019-04-16 | 미쓰비시 타나베 파마 코퍼레이션 | 이환식 함질소 헤테로환 화합물 |
| WO2023243659A1 (ja) * | 2022-06-15 | 2023-12-21 | 真一 松本 | 線条体ストリオソームのドパミンｄ１シグナルを標的とした強迫性障害の薬物療法 |
| EP4572765A1 (en) * | 2022-08-18 | 2025-06-25 | Mitodicure GmbH | Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7932250B2 (en) * | 2004-07-01 | 2011-04-26 | Daiichi Sankyo Company, Limited | Thienopyrazole derivative having PDE7 inhibitory activity |
| US20060183763A1 (en) * | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
| PL1928438T3 (pl) * | 2005-09-26 | 2013-08-30 | Avigen Inc | Zastosowanie ibudilastu do leczenia uzależnień od środków odurzających |
| US8637528B2 (en) * | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
| EP2139475B1 (en) * | 2007-03-27 | 2014-12-17 | Omeros Corporation | PDE7 inhibitors for use in the treatment of movement disorders |
| ES2830073T3 (es) * | 2007-04-11 | 2021-06-02 | Omeros Corp | Composiciones y métodos para la profilaxis y el tratamiento de adicciones |
| FR2943673B1 (fr) * | 2009-03-27 | 2013-03-29 | Sanofi Aventis | Applications therapeutiques de derives de quinazolinedione |
| FR2944282B1 (fr) * | 2009-04-09 | 2013-05-03 | Sanofi Aventis | Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques |
| NZ628055A (en) * | 2010-11-08 | 2016-03-31 | Omeros Corp | Treatment of addiction and impulse-control disorders using pde7 inhibitors |
-
2013
- 2013-05-07 EP EP13793319.8A patent/EP2846805B1/en active Active
- 2013-05-07 SI SI201331354T patent/SI2846805T1/sl unknown
- 2013-05-07 CA CA2871151A patent/CA2871151C/en active Active
- 2013-05-07 IN IN10404DEN2014 patent/IN2014DN10404A/en unknown
- 2013-05-07 CN CN202210569437.1A patent/CN114984229A/zh active Pending
- 2013-05-07 CN CN201380036048.1A patent/CN104768556A/zh active Pending
- 2013-05-07 RS RS20190228A patent/RS58381B1/sr unknown
- 2013-05-07 WO PCT/US2013/039866 patent/WO2013176877A2/en not_active Ceased
- 2013-05-07 PL PL13793319T patent/PL2846805T3/pl unknown
- 2013-05-07 JP JP2015511605A patent/JP2015521177A/ja active Pending
- 2013-05-07 AU AU2013266793A patent/AU2013266793B2/en active Active
- 2013-05-07 CN CN202011054538.2A patent/CN112168972A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN114984229A (zh) | 2022-09-02 |
| CA2871151A1 (en) | 2013-11-28 |
| AU2013266793A1 (en) | 2014-11-27 |
| WO2013176877A2 (en) | 2013-11-28 |
| EP2846805A2 (en) | 2015-03-18 |
| SI2846805T1 (sl) | 2019-04-30 |
| PL2846805T3 (pl) | 2019-05-31 |
| RS58381B1 (sr) | 2019-04-30 |
| AU2013266793B2 (en) | 2016-08-04 |
| WO2013176877A3 (en) | 2015-06-18 |
| CN104768556A (zh) | 2015-07-08 |
| EP2846805A4 (en) | 2016-08-10 |
| CN112168972A (zh) | 2021-01-05 |
| EP2846805B1 (en) | 2018-11-21 |
| CA2871151C (en) | 2019-03-26 |
| JP2015521177A (ja) | 2015-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX389018B (es) | Tratamiento de trastornos de adiccion y control de impulsos usando inhibidores de pde7. | |
| MX356525B (es) | Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia. | |
| PT2825161T (pt) | Inibidores de ezh2 humana e métodos de uso dos mesmos | |
| MX351464B (es) | El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas. | |
| IN2014CN04014A (cg-RX-API-DMAC7.html) | ||
| MY181602A (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
| PH12015502302B1 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
| PH12014500925A1 (en) | Therapeutic combinations and methods of treating melanoma | |
| IN2014DN10404A (cg-RX-API-DMAC7.html) | ||
| PL2780025T3 (pl) | Zastosowanie ekstraktów z wiązówki (Filipendula) do leczenia i profilaktyki przewlekłych stanów bólowych | |
| MX2013002121A (es) | Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
| MX2016008150A (es) | Formulaciones de berberina y usos de las mismas. | |
| UA111520C2 (uk) | [1,2,4]триазолопіридини і їх застосування як інгібіторів фосфодіестерази | |
| MX2016005614A (es) | Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos. | |
| MX2016003293A (es) | Metodos y composiciones para el tratamiento de una infeccion por clamidia y enfermedades y trastornos relacionados. | |
| WO2012097121A9 (en) | Specific nnos inhibitors for the therapy and prevention of human melanoma | |
| MY200803A (en) | Mpo inhibitors for use in medicine | |
| ZA201600312B (en) | Therapeutic agents for use in the prophylaxis and/or treatment of hyperkinetic movement disorders | |
| CO7151515A2 (es) | Métodos para tratar deficiencia en la marcha y/o equilibrio en pacientes con esclerosis múltiple que utilizan una aminopiridina | |
| HUE041294T2 (hu) | TRPC4 modulátorok a fájdalom kezelésére vagy megelõzésére | |
| PT2846805T (pt) | Macrociclos peptidomiméticos | |
| EP2934699A4 (en) | PLOD2 GENE STIMULATORS AND USE OF SAID STIMULATORS FOR TREATING SKIN | |
| MX2013006527A (es) | Derivados de arilsulfonamida para la prevencion o el tratamiento de los trastornos oftalmologicos especificos. | |
| AU2013101402A4 (en) | Timber treatment formulations and methods of use |